608 related articles for article (PubMed ID: 16621226)
21. Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial.
Baggio MR; Martins WP; Calderon AC; Berezowski AT; Marcolin AC; Duarte G; Cavalli RC
Ultrasound Med Biol; 2011 Jan; 37(1):53-8. PubMed ID: 21084154
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial.
S D; Novri DA; Hamidy Y; Savira M
F1000Res; 2022; 11():1287. PubMed ID: 37273965
[No Abstract] [Full Text] [Related]
23. Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women.
Chera-Aree P; Tengtrakulcharoen P; Leetheeragul J; Sampaojarean U; Surasereewong S; Wataganara T
J Clin Pharmacol; 2020 Dec; 60(12):1662-1670. PubMed ID: 32598488
[TBL] [Abstract][Full Text] [Related]
24. [Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive agents].
Walss Rodriguez RJ; Flores Padilla LM
Ginecol Obstet Mex; 1993 Mar; 61():76-9. PubMed ID: 8454221
[TBL] [Abstract][Full Text] [Related]
25. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.
Magee LA; Cham C; Waterman EJ; Ohlsson A; von Dadelszen P
BMJ; 2003 Oct; 327(7421):955-60. PubMed ID: 14576246
[TBL] [Abstract][Full Text] [Related]
26. [Clinical efficacy and perinatal outcome of nifedipine for severe preeclampsia: meta-analysis].
Liu QQ; Yu YH; Gong SP; Huang LP
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):592-7. PubMed ID: 23141179
[TBL] [Abstract][Full Text] [Related]
27. Comparing Intravenous Labetalol and Intravenous Hydralazine for Managing Severe Gestational Hypertension.
Ehikioya E; Okobi OE; Beeko MAE; Abanga R; Abah NNI; Briggs L; Nwimo PN; Beeko PKA; Nwachukwu OB; Okoroafor CC
Cureus; 2023 Jul; 15(7):e42332. PubMed ID: 37614273
[TBL] [Abstract][Full Text] [Related]
28. Effect of L-arginine on blood pressure in pregnancy-induced hypertension: a randomized placebo-controlled trial.
Neri I; Jasonni VM; Gori GF; Blasi I; Facchinetti F
J Matern Fetal Neonatal Med; 2006 May; 19(5):277-81. PubMed ID: 16753767
[TBL] [Abstract][Full Text] [Related]
29. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
[TBL] [Abstract][Full Text] [Related]
30. Controversies Regarding Diagnosis and Treatment of Severe Hypertension in Pregnancy.
Barton JR; Sibai BM
Clin Obstet Gynecol; 2017 Mar; 60(1):198-205. PubMed ID: 28005594
[TBL] [Abstract][Full Text] [Related]
31. Treatment of severe and resistant hypertension.
Pearson RM; Havard CW
Br J Hosp Med; 1978 Oct; 20(4):447-55. PubMed ID: 31216
[No Abstract] [Full Text] [Related]
32. [Use of labetalol in the treatment of hypertensive crises].
Semplicini A; Pessina AC; Rossi GP; Palatini P; Hlede M; Morandin F; Visonà A; Mazzucato A; Dal Palù C
G Ital Cardiol; 1982; 12(5):355-8. PubMed ID: 7152187
[TBL] [Abstract][Full Text] [Related]
33. Neonatal side effects of maternal labetalol treatment in severe preeclampsia.
Heida KY; Zeeman GG; Van Veen TR; Hulzebos CV
Early Hum Dev; 2012 Jul; 88(7):503-7. PubMed ID: 22525036
[TBL] [Abstract][Full Text] [Related]
34. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
Firoz T; Magee LA; MacDonell K; Payne BA; Gordon R; Vidler M; von Dadelszen P;
BJOG; 2014 Sep; 121(10):1210-8; discussion 1220. PubMed ID: 24832366
[TBL] [Abstract][Full Text] [Related]
35. Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial.
Sharma C; Soni A; Gupta A; Verma A; Verma S
Am J Obstet Gynecol; 2017 Dec; 217(6):687.e1-687.e6. PubMed ID: 28867601
[TBL] [Abstract][Full Text] [Related]
36. [Management of severe pre-eclampsia in the puerperium. Comparative study of sublingual nifedipine and hydralazine].
Walss Rodríguez RJ; Villarreal Ordaz F
Ginecol Obstet Mex; 1991 Jul; 59():207-10. PubMed ID: 1769603
[TBL] [Abstract][Full Text] [Related]
37. Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients.
Malesker MA; Hilleman DE
J Crit Care; 2012 Oct; 27(5):528.e7-14. PubMed ID: 22300487
[TBL] [Abstract][Full Text] [Related]
38. [Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial].
Plouin PF; Bréart G; Maillard F; Papiernik E; Relier JP
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):952-5. PubMed ID: 3116996
[TBL] [Abstract][Full Text] [Related]
39. Impedance cardiography assessed treatment of acute severe pregnancy hypertension: a randomized trial.
Morris R; Sunesara I; Darby M; Novotny S; Kiprono L; Bautista L; Sawardecker S; Bofill J; Anderson B; Martin JN
J Matern Fetal Neonatal Med; 2016; 29(2):171-6. PubMed ID: 25483419
[TBL] [Abstract][Full Text] [Related]
40. The optimal treatment of severe hypertension in pregnancy: update of the role of nicardipine.
Nooij LS; Visser S; Meuleman T; Vos P; Roelofs R; de Groot CJ
Curr Pharm Biotechnol; 2014; 15(1):64-9. PubMed ID: 24720593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
